Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 220 | -218 | 150 | 14 | 476 |
| Cost of Goods | N/A | -262 | 1 | 1 | 262 |
| Gross Profit | 220 | 44 | 149 | 13 | 214 |
| Operating Expenses | 226 | -1,128 | 143 | 115 | 1,570 |
| Operating Income | -6 | 910 | 7 | -101 | -1,094 |
| Interest Expense | 0 | 0 | 1 | 0 | 0 |
| Other Income | 0 | -19 | 0 | 0 | 19 |
| Pre-tax Income | -6 | 891 | 7 | -101 | -1,075 |
| Net Income Continuous | -6 | -704 | 7 | -101 | -1,075 |
| Net Income Discontinuous | -379 | -126 | -1,141 | -1,270 | N/A |
| Net Income | $-385 | $-830 | $-1,134 | $-1,371 | $-1,075 |
| EPS Basic Total Ops | -0.42 | -0.98 | -1.26 | -1.54 | -1.26 |
| EPS Basic Continuous Ops | -0.01 | -0.75 | 0.01 | -0.14 | -1.21 |
| EPS Basic Discontinuous Ops | -0.42 | -0.28 | -1.26 | -1.40 | N/A |
| EPS Diluted Total Ops | -0.42 | -4.12 | -0.92 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.01 | -2.11 | 0.01 | N/A | N/A |
| EPS Diluted Discontinuous Ops | -0.42 | -2.01 | -0.93 | N/A | N/A |
| EBITDA(a) | $0 | $916 | $9 | $-168 | $-1,024 |